Displaying drugs 7926 - 7950 of 8030 in total
Adomiparin
Investigational
Acetylcysteine zidrimer
Investigational
Siplizumab
Investigational
RG-7795
Investigational
Vitespen
Investigational
PRX-07034
Investigational
Sufugolix
Investigational
Alicaforsen
Investigational
BG-777
BG-777 is an immunomodulator with proven efficacy against viral and bacterial infections in preclinical studies.
Investigational
Quisovalimab
Investigational
Darapladib
Investigational
Lanoteplase
Investigational
RAV12
RAV12 is investigated for use/treatment in solid tumors. RAV12 is a solid. RAV12 is a chimeric antibody that recognizes RAAG12, an N-linked carbohydrate antigen found on gastric, colon, pancreatic, prostate, ovarian, breast, and kidney cancer cells.
Investigational
Methopterin
Methopterin is thought to have effects on osteoclasts and to inhibit inflammatory bone destruction.
Investigational
Latiglutenase
Investigational
Morphine glucuronide
Investigational
Elsiglutide
Investigational
Elvucitabine
Investigational
Labetuzumab
Labetuzumab is a humanized monoclonal antibody to carcinoembryonic antigen that inhibits tumor growth. It is used in radioimmunotherapy.
Investigational
Teprenone
Experimental
TAS-108
Investigational
LX6171
LX6171 is an oral drug candidate that was generated by Lexicon medicinal chemists and is being developed to treat disorders characterized by cognitive impairment, such as Alzheimer's disease, schizophrenia or vascular dementia.
Investigational
MAS825
Investigational
PPI-1019
Apan (PPI-1019) is developed by Praecis Pharmaceuticals to treat Alzheimer's Disease.
Investigational
4-O-Demethylpenclomedine
Investigational
Displaying drugs 7926 - 7950 of 8030 in total